Clear Eyes Redness Relief
NDC 67172-797, Naphazoline Hydrochloride and Glycerin, liquid, from Prestige Brands Holdings, Inc..
- Product NDC
- 67172-797
- Status
- Listed
- Labeler
- Prestige Brands Holdings, Inc.
- Dosage form
- LIQUID
- Route
- OPHTHALMIC
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M018
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67172-797 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPHAZOLINE HYDROCHLORIDE.12 mg/mL
- GLYCERIN2.5 mg/mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67172-797-01 | 67172079701 | 1 BOTTLE in 1 BOX (67172-797-01) / 30 mL in 1 BOTTLE |
| 67172-797-15 | 67172079715 | 1 BOTTLE, DROPPER in 1 CARTON (67172-797-15) / 15 mL in 1 BOTTLE, DROPPER |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 67172-797 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67172-797 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67172-797. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.